Thought leadership conversations on Revenue Optimization, Regulatory Environment and New Regulatory Compliance Strategies
REDWOOD CITY, CA – September 9th – Model N, Inc. (NYSE: MODN), the leading Revenue Management solutions provider to the life science and technology industries, announced today that it will be sponsoring two prominent life sciences events, The Institute for International Research 19th Annual Summit on the Medicaid Drug Rebate Program (MDRP) on September 15-17 in Chicago and the 2nd Annual Medical Device Strategic Pricing Conference on September 15-16 in Atlanta, as well as a FierceHealth Webinar “New Regulatory Compliance – Strategies for Pharma Leaders” on September 25 at 11a PT/2p ET.
Now in its 19th year, IIR’s Medicaid Drug Rebate Program Summit continues as the authoritative MDRP event for everything government pricing, rebates and regulations. Jesse Mendelsohn, Director, Global Customer Services & Support at Model N will be presenting “Revenue Optimization: What should manufacturers be doing in this period of change?” and Scott Medberry, Director of Product Management, Model N will be presenting “Managing Increasing 340B Volumes Effectively in a Changing Regulatory Environment.”
“The true implications and effects of the Affordable Care Act are now unfolding, yet there are still many questions about how all of these regulatory changes are going to affect the Medicaid Drug Rebate Program as well as other government and commercial purchasing programs,” said Shail Khiyara, Senior Vice President & Chief Marketing Officer, Model N. “Through this sponsorship and executive presenters, Model N continues its thought leadership with major regulatory changes due to the impact of the ACA and AMP Final Rule.”
At the 2nd Annual Medical Device Strategic Pricing Conference, Model N Sr. Director, Product ManagementNate Taninecz will be joined by industry thought leader and author Christopher Provines, CEO, Value Vantage Partners on “Med Tech Contracting & Pricing: Driving Profitable Growth.”
“Model N is a key provider to medical device companies and has an end-to-end Revenue Management solution tailored to their needs,” Provines said. “They continue to drive customer value in discount management, contract compliance, and educating the industry on trends and upcoming challenges on margin erosion with best practices that customers can use.”
In addition, Model N will be participating in a FierceHealth Webinar “New Regulatory Compliance – Strategies for Pharma Leaders,” featuring contracting, pricing and reimbursement consultant, Miree Lee, M. Lee Consulting, LLC and Scott Medberry, Director, Product Management, Model N on September 25 at 11a PT/2p ET.
“Regulatory changes are repeatedly impacting the bottom line for both government and commercial programs,” said Lee. “This webinar will focus on why manufacturers participate in government programs, the obligations associated with such participation, the interconnectivity between various government programs, and the link between commercial pricing and contracting on government pricing.”
About Model N
Model N is the leader in Revenue Management solutions. Model N helps its customers maximize their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line encompassing contracting, pricing, incentives, and rebates. Model N leverages its deep industry expertise to support the unique business needs of Life Science and Technology companies across more than 100 countries. Global Customers include: Actavis, Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.
Model N® is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.
Connect with Model N